BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Groot AS, Moise L, Terry F, Gutierrez AH, Hindocha P, Richard G, Hoft DF, Ross TM, Noe AR, Takahashi Y, Kotraiah V, Silk SE, Nielsen CM, Minassian AM, Ashfield R, Ardito M, Draper SJ, Martin WD. Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools. Front Immunol 2020;11:442. [PMID: 32318055 DOI: 10.3389/fimmu.2020.00442] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Richard G, De Groot AS, Steinberg GD, Garcia TI, Kacew A, Ardito M, Martin WD, Berdugo G, Princiotta MF, Balar AV, Sweis RF. Multi-step screening of neoantigens' HLA- and TCR-interfaces improves prediction of survival. Sci Rep 2021;11:9983. [PMID: 33976291 DOI: 10.1038/s41598-021-89016-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ghandadi M. An Immunoinformatic Strategy to Develop New Mycobacterium tuberculosis Multi-epitope Vaccine. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-022-10406-0] [Reference Citation Analysis]
3 Plant EP, Manukyan H, Laassri M, Ye Z. Insights from the comparison of genomic variants from two influenza B viruses grown in the presence of human antibodies in cell culture. PLoS One 2020;15:e0239015. [PMID: 32925936 DOI: 10.1371/journal.pone.0239015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jafari E, Mahmoodi S. Design, expression, and purification of a multi-epitope vaccine against Helicobacter Pylori based on Melittin as an adjuvant. Microb Pathog 2021;157:104970. [PMID: 34022362 DOI: 10.1016/j.micpath.2021.104970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Khalid K, Irum S, Ullah SR, Andleeb S. In-Silico Vaccine Design Based on a Novel Vaccine Candidate Against Infections Caused by Acinetobacter baumannii. Int J Pept Res Ther 2022;28:16. [PMID: 34873398 DOI: 10.1007/s10989-021-10316-7] [Reference Citation Analysis]
6 Maine CJ, Richard G, Spasova DS, Miyake-Stoner SJ, Sparks J, Moise L, Sullivan RP, Garijo O, Choz M, Crouse JM, Aguilar A, Olesiuk MD, Lyons K, Salvador K, Blomgren M, DeHart JL, Kamrud KI, Berdugo G, De Groot AS, Wang NS, Aliahmad P. Self-Replicating RNAs Drive Protective Anti-tumor T Cell Responses to Neoantigen Vaccine Targets in a Combinatorial Approach. Mol Ther 2021;29:1186-98. [PMID: 33278563 DOI: 10.1016/j.ymthe.2020.11.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 De Groot AS, Desai AK, Lelias S, Miah SMS, Terry FE, Khan S, Li C, Yi JS, Ardito M, Martin WD, Kishnani PS. Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease. Front Immunol 2021;12:636731. [PMID: 34220802 DOI: 10.3389/fimmu.2021.636731] [Reference Citation Analysis]
8 Tucker KD, Schanen BC, Phares TW, Sassano E, Terry FE, Hindocha P, Moise L, Kotraiah V, Martin WD, De Groot AS, Drake DR 3rd, Gutierrez GM, Noe AR. Identification, Selection and Immune Assessment of Liver Stage CD8 T Cell Epitopes From Plasmodium falciparum. Front Immunol 2021;12:684116. [PMID: 34025684 DOI: 10.3389/fimmu.2021.684116] [Reference Citation Analysis]
9 Moise L, Ross TM, Hoft DF, Martin WD, De Groot AS. Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines. Expert Rev Vaccines 2020;19:781-4. [PMID: 32962468 DOI: 10.1080/14760584.2020.1825946] [Reference Citation Analysis]
10 Moise L, Gutiérrez AH, Khan S, Tan S, Ardito M, Martin WD, De Groot AS. New Immunoinformatics Tools for Swine: Designing Epitope-Driven Vaccines, Predicting Vaccine Efficacy, and Making Vaccines on Demand. Front Immunol 2020;11:563362. [PMID: 33123135 DOI: 10.3389/fimmu.2020.563362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Oyarzun P, Kashyap M, Fica V, Salas-Burgos A, Gonzalez-Galarza FF, McCabe A, Jones AR, Middleton D, Kobe B. A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach. Front Immunol 2021;12:598778. [PMID: 33717077 DOI: 10.3389/fimmu.2021.598778] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Tourdot S, Quaglia CB, Chamberlain P, De Groot AS, Dellas N, Guillemare E, Kromminga A, Lotz GP, Mingozzi F, Piccoli L, Pine S, Richards S, Waxenecker G, Kramer D. European Immunogenicity Platform 11th Open Scientific Symposium on immunogenicity of biopharmaceuticals. Bioanalysis 2020;12:1043-8. [DOI: 10.4155/bio-2020-0150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Di Natale C, La Manna S, De Benedictis I, Brandi P, Marasco D. Perspectives in Peptide-Based Vaccination Strategies for Syndrome Coronavirus 2 Pandemic. Front Pharmacol 2020;11:578382. [PMID: 33343349 DOI: 10.3389/fphar.2020.578382] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
14 Wang D, Mai J, Zhou W, Yu W, Zhan Y, Wang N, Epstein ND, Yang Y. Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines (Basel) 2020;8:E355. [PMID: 32635180 DOI: 10.3390/vaccines8030355] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 12.0] [Reference Citation Analysis]
15 Bonin CRB, Fernandes GC, de Menezes Martins R, Camacho LAB, Teixeira-Carvalho A, da Mota LMH, de Lima SMB, Campi-Azevedo AC, Martins-Filho OA, Dos Santos RW, Lobosco M; Collaborative Group for Studies of Yellow Fever Vaccine. Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals. BMC Bioinformatics 2020;21:551. [PMID: 33308151 DOI: 10.1186/s12859-020-03845-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Adam L, Rosenbaum P, Bonduelle O, Combadière B. Strategies for Immunomonitoring after Vaccination and during Infection. Vaccines (Basel) 2021;9:365. [PMID: 33918841 DOI: 10.3390/vaccines9040365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Noe AR, Terry FE, Schanen BC, Sassano E, Hindocha P, Phares TW, Moise L, Christen JM, Tucker KD, Kotraiah V, Drake DR 3rd, Martin WD, De Groot AS, Gutierrez GM. Bridging Computational Vaccinology and Vaccine Development Through Systematic Identification, Characterization, and Downselection of Conserved and Variable Circumsporozoite Protein CD4 T Cell Epitopes From Diverse Plasmodium falciparum Strains. Front Immunol 2021;12:689920. [PMID: 34168657 DOI: 10.3389/fimmu.2021.689920] [Reference Citation Analysis]
18 Cheng JH, Wang H, Sun DW. An overview of tropomyosin as an important seafood allergen: Structure, cross-reactivity, epitopes, allergenicity, and processing modifications. Compr Rev Food Sci Food Saf 2021. [PMID: 34954871 DOI: 10.1111/1541-4337.12889] [Reference Citation Analysis]
19 Shahgolzari M, Yavari A, Arjeini Y, Miri SM, Darabi A, Mozaffari Nejad AS, Keshavarz M. Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn. Gene Rep 2021;25:101417. [PMID: 34778602 DOI: 10.1016/j.genrep.2021.101417] [Reference Citation Analysis]
20 Uttarilli A, Amalakanti S, Kommoju PR, Sharma S, Goyal P, Manjunath GK, Upadhayay V, Parveen A, Tandon R, Prasad KS, Dakal TC, Ben Shlomo I, Yousef M, Neerathilingam M, Kumar A. Super-rapid race for saving lives by developing COVID-19 vaccines. J Integr Bioinform 2021;18:27-43. [PMID: 33761582 DOI: 10.1515/jib-2021-0002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Richard G, Princiotta MF, Bridon D, Martin WD, Steinberg GD, De Groot AS. Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy. Expert Rev Vaccines 2021;:1-12. [PMID: 34882038 DOI: 10.1080/14760584.2022.2012456] [Reference Citation Analysis]
22 Meyers LM, Gutiérrez AH, Boyle CM, Terry F, McGonnigal BG, Salazar A, Princiotta MF, Martin WD, De Groot AS, Moise L. Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation. NPJ Vaccines 2021;6:71. [PMID: 33986292 DOI: 10.1038/s41541-021-00331-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Warimwe GM, Francis MJ, Bowden TA, Thumbi SM, Charleston B. Using cross-species vaccination approaches to counter emerging infectious diseases. Nat Rev Immunol 2021. [PMID: 34140665 DOI: 10.1038/s41577-021-00567-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Winterling K, Martin WD, De Groot AS, Daufenbach J, Kistner S, Schüttrumpf J. Development of a novel fully functional coagulation factor VIII with reduced immunogenicity utilizing an in silico prediction and deimmunization approach. J Thromb Haemost 2021;19:2161-70. [PMID: 34060724 DOI: 10.1111/jth.15413] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Kotraiah V, Phares TW, Terry FE, Hindocha P, Silk SE, Nielsen CM, Moise L, Tucker KD, Ashfield R, Martin WD, De Groot AS, Draper SJ, Gutierrez GM, Noe AR. Identification and Immune Assessment of T Cell Epitopes in Five Plasmodium falciparum Blood Stage Antigens to Facilitate Vaccine Candidate Selection and Optimization. Front Immunol 2021;12:690348. [PMID: 34305923 DOI: 10.3389/fimmu.2021.690348] [Reference Citation Analysis]
26 Jahangirian E, Jamal GA, Nouroozi M, Mohammadpour A. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2. Immunogenetics 2021;73:459-77. [PMID: 34542663 DOI: 10.1007/s00251-021-01228-3] [Reference Citation Analysis]
27 Cohen S, Chung S, Spiess C, Lundin V, Stefanich E, Laing ST, Clark V, Brumm J, Zhou Y, Huang C, Guerrero J, Myneni S, Yadav R, Siradze K, Peng K. An integrated approach for characterizing immunogenic responses toward a bispecific antibody. MAbs 2021;13:1944017. [PMID: 34225571 DOI: 10.1080/19420862.2021.1944017] [Reference Citation Analysis]
28 Opriessnig T, Mattei AA, Karuppannan AK, Halbur PG. Future perspectives on swine viral vaccines: where are we headed? Porcine Health Manag 2021;7:1. [PMID: 33397477 DOI: 10.1186/s40813-020-00179-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Ostuni A, Monné M, Crudele MA, Cristinziano PL, Cecchini S, Amati M, De Vendel J, Raimondi P, Chassalevris T, Dovas CI, Bavoso A. Design and structural bioinformatic analysis of polypeptide antigens useful for the SRLV serodiagnosis. J Virol Methods 2021;297:114266. [PMID: 34454989 DOI: 10.1016/j.jviromet.2021.114266] [Reference Citation Analysis]
30 Feodorova VA, Lyapina AM, Khizhnyakova MA, Zaitsev SS, Saltykov YV, Motin VL. Yersinia pestis Antigen F1 but Not LcrV Induced Humoral and Cellular Immune Responses in Humans Immunized with Live Plague Vaccine-Comparison of Immunoinformatic and Immunological Approaches. Vaccines (Basel) 2020;8:E698. [PMID: 33228200 DOI: 10.3390/vaccines8040698] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]